What OptiPin's sourced rule file says about Tamoxifen with Letrozole (Nolvadex and Femara): the combination first, then what each one adds alone, then one bloodwork plan for both. It names markers and red flags, never doses.
This page describes a pair, not you. If you have chest pain, trouble breathing, weakness or numbness on one side, yellowing of your skin or eyes, or shaking, sweating and confusion that could be low blood sugar, get urgent medical care now. Nothing here is a dose, a protocol or a safety verdict.
What the rules say about the combination
1 rule fires only when both compounds are present. Each card is rendered from OptiPin's public, sourced rule file. Its labels show the evidence behind each claim (how we label evidence).
Interaction · label or pharmacokinetic evidence for the combination
Tamoxifen lowers anastrozole and letrozole levels Drug label
Flagged by: Tamoxifen, Letrozole
Tamoxifen lowers anastrozole blood levels by about 27% and letrozole by about 38%. The anastrozole and tamoxifen labels say not to combine them, mainly because the pair showed no added benefit in breast-cancer trials.
In those studies (postmenopausal women) estradiol suppression held despite the lower levels, so what this means for estradiol in men is not known.
Markers to check
Estradiol (sensitive assay) before starting and again after any change to either drug
How this is usually handled Drug label
The labels advise against using the two together; a clinician decides which one fits.
Evidence
Strong for the drop in drug levels (labels plus pharmacokinetic studies); the same studies found no significant effect on estradiol suppression.
Log a cycle in OptiPin and it shows whether the stack converts to estradiol, which compounds are 19-nors or 17α-alkylated, when red cell count tends to climb and when your own production is shut down, each with the marker that reads it. All on-device.
Tamoxifen lowers anastrozole blood levels by about 27% and letrozole by about 38%. The anastrozole and tamoxifen labels say not to combine them, mainly because the pair showed no added benefit in breast-cancer trials. In those studies (postmenopausal women) estradiol suppression held despite the lower levels, so what this means for estradiol in men is not known.
How is this usually handled on Tamoxifen and Letrozole?
The labels advise against using the two together; a clinician decides which one fits.
What is worth monitoring on Tamoxifen and Letrozole?
Estradiol (sensitive assay) before starting and again after any change to either drug.
OptiPin